文献速递心脑血管急症重症综合管理与镇静镇痛

社区老年人群创伤性脑损伤伴与不伴意识丧失与神经病理结局的关联

Association of Traumatic Brain Injury With and Without Loss of Consciousness With Neuropathologic Outcomes in Community-Dwelling Older Persons.
PubMed 文献 · JAMA Netw Open · 2022-04-01
一句话结论社区老年人群横断面分析提示,即使不伴意识丧失的创伤性脑损伤史也与神经退行性和血管性神经病理结局相关。

该横断面分析纳入宗教修会研究、拉什记忆与老化项目及少数族裔老化研究共1689名社区老年人,根据标准化自报问卷分为无创伤性脑损伤暴露组(n=1024)、伴意识丧失的创伤性脑损伤组(n=161)和不伴意识丧失的创伤性脑损伤组(n=504),评估淀粉样蛋白β、配对螺旋丝缠结、新皮质路易体、TAR DNA结合蛋白43、海马硬化、大体梗死和微梗死等神经病理指标。调整死亡年龄、性别和教育水平后,伴意识丧失的创伤性脑损伤与更高的淀粉样蛋白β负荷(估计值0.25;95%CI 0.06-0.43;P=.008)及≥1个大体重梗死(OR 1.45;95%CI 1.04-2.02;P=.02)、≥1个微梗死(OR 1.70;95%CI 1.21-2.38;P=.002)、尤其皮质下微梗死(OR 1.85;95%CI 1.23-2.79;P=.002)的更高比值相关;不伴意识丧失的创伤性脑损伤与新皮质路易体(OR 1.37;95%CI 1.01-1.87;P=.04)和≥1个皮质微梗死(OR 1.43;95%CI 1.09-1.87;P=.008)的更高比值相关。控制血管危险因素和血管疾病负担后,创伤性脑损伤与血管病理结局的关联持续存在;创伤性脑损伤伴或不伴意识丧失均与配对螺旋丝缠结、TAR DNA结合蛋白43或海马硬化无关,未发现APOE ε4或性别交互作用。作者认为,即使不伴意识丧失的创伤性脑损伤史也

要点

  • 伴意识丧失的创伤性脑损伤史与更高淀粉样蛋白β负荷相关(估计值0.25;95%CI 0.06-0.43;P=.008)。
  • 伴意识丧失的创伤性脑损伤史与≥1个大体重梗死(OR 1.45;95%CI 1.04-2.02;P=.02)和≥1个微梗死(OR 1.70;95%CI 1.21-2.38;P=.002)比值更高相关。
  • 不伴意识丧失的创伤性脑损伤史与新皮质路易体(OR 1.37;95%CI 1.01-1.87;P=.04)和≥1个皮质微梗死(OR 1.43;95%CI 1.09-1.87;P=.008)比值更高相关。
  • 控制血管危险因素和血管疾病负担后,创伤性脑损伤与血管病理结局的关联持续存在。
  • 创伤性脑损伤伴或不伴意识丧失均与配对螺旋丝缠结、TAR DNA结合蛋白43或海马硬化无关,未发现APOE ε4或性别交互作用。

适用人群与场景

  • 来自宗教修会研究、拉什记忆与老化项目和少数族裔老化研究的1689名社区老年人;1138名(67%)女性、551名(33%)男性;死亡时平均(SD)年龄89.2(6.7)岁;80名(5%)黑人、46名(3%)拉丁裔、1639名(97%)非拉丁裔、1601名(95%)白人。
  • 创伤性脑损伤暴露通过基线和每年随访时的标准化自报问卷评估,分为无创伤性脑损伤暴露组(n=1024)、伴意识丧失的创伤性脑损伤组(n=161)和不伴意识丧失的创伤性脑损伤组(n=504)。

研究设计与关键结果

  • 研究类型:横断面分析;数据来自宗教修会研究、拉什记忆与老化项目和少数族裔老化研究,分别于1994年、1997年和2004年开始入组;当前研究数据集于2021年4月3日冻结,届时参与者平均(SD)随访时间为8.7(5.5)年。
  • 与无创伤性脑损伤参与者相比,伴意识丧失的创伤性脑损伤参与者淀粉样蛋白β负荷更高(估计值0.25;95%CI 0.06-0.43;P=.008),≥1个大体重梗死比值更高(OR 1.45;95%CI 1.04-2.02;P=.02),≥1个微梗死比值更高(OR 1.70;95%CI 1.21-2.38;P=.002),尤其皮质下微梗死(OR 1.85;95%CI 1.23-2.79;P=.002)。
  • 与无创伤性脑损伤参与者相比,不伴意识丧失的创伤性脑损伤参与者新皮质路易体比值更高(OR 1.37;95%CI 1.01-1.87;P=.04),≥1个皮质微梗死比值更高(OR 1.43;95%CI 1.09-1.87;P=.008)。
  • 控制血管危险因素和血管疾病负担后,创伤性脑损伤伴或不伴意识丧失与血管病理结局的关联持续存在。
  • 创伤性脑损伤伴或不伴意识丧失均与配对螺旋丝缠结、TAR DNA结合蛋白43或海马硬化无关;未发现APOE ε4或性别交互作用。

证据类型、等级与局限

  • 证据类型:横断面分析。
  • 作者结论:该横断面分析提示,即使不伴意识丧失的创伤性脑损伤史也与年龄相关的神经病理结局相关,包括神经退行性和血管性;伴与不伴意识丧失者神经病理结局的差异可能为创伤性脑损伤患者的潜在机制、诊断和管理提供线索。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,即使不伴意识丧失的创伤性脑损伤史也与年龄相关的神经退行性和血管性神经病理结局相关;伴与不伴意识丧失者神经病理结局的差异可能为创伤性脑损伤患者的潜在机制、诊断和管理提供线索。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: A history of traumatic brain injury (TBI) has been considered a risk factor for Alzheimer dementia. However, the specific association of TBI, even without loss of consciousness (LOC), with pathologic findings that underlie Alzheimer dementia, including Alzheimer disease (AD), non-AD neurodegenerative, and vascular pathologic findings, remains unclear.

OBJECTIVE: To examine the association between TBI with and without LOC and neuropathologic findings in community-based cohorts.

DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional analysis used neuropathologic data from 1689 participants from the Religious Orders Study, the Rush Memory and Aging Project, and the Minority Aging Research Study. These studies began enrollment in 1994, 1997, and 2004, respectively. The current study's data set was frozen on April 3, 2021, when the mean (SD) length of follow-up for the participants was 8.7 (5.5) years.

EXPOSURE: Traumatic brain injury exposure was assessed using a standardized, self-reported questionnaire at baseline and annual follow-up visits. Participants were categorized into those (1) without TBI exposure (n = 1024), (2) with TBI with LOC (n = 161), or (3) with TBI without LOC (n = 504).

MAIN OUTCOMES AND MEASURES: Neuropathologic measures of amyloid-β, paired helical filament tangles, neocortical Lewy bodies, transactive response DNA-binding protein 43, hippocampal sclerosis, gross infarcts, and microinfarcts were assessed. Multiple linear regression and logistic regression models were used to determine whether TBI with or without LOC (compared with no TBI exposure as the reference group) was associated with neuropathologic outcomes after adjusting for age at death, sex, and educational level. Whether the apolipoprotein E (APOE) ε4 allele and sex differences modified associations was also examined.

RESULTS: A total of 1689 participants (1138 [67%] women and 551 [33%] men; mean [SD] age at death, 89.2 [6.7] years; 80 [5%] Black, 46 [3%] Latino, 1639 [97%] non-Latino, and 1601 [95%] White) participated in the study. Compared with participants without TBI, participants with TBI with LOC had a greater amyloid-β load (estimate, 0.25; 95% CI, 0.06-0.43; P = .008) and higher odds of having 1 or more gross infarcts (odds ratio [OR], 1.45; 95% CI, 1.04-2.02; P = .02) and 1 or more microinfarcts (OR, 1.70; 95% CI, 1.21-2.38; P = .002), particularly subcortical microinfarcts (OR, 1.85; 95% CI, 1.23-2.79; P = .002). Those with TBI without LOC had higher odds of neocortical Lewy bodies (OR, 1.37; 95% CI, 1.01-1.87; P = .04) and 1 or more cortical microinfarcts (OR, 1.43; 95% CI, 1.09-1.87; P = .008). The association of TBI with and without LOC with vascular pathologic outcomes persisted after controlling for vascular risk factors and vascular disease burden. Traumatic brain injury with or without LOC was not associated with paired helical filament tangles, transactive response DNA-binding protein 43, or hippocampal sclerosis. No interactions occurred with APOE ε4 or sex.

CONCLUSIONS AND RELEVANCE: This cross-sectional analysis suggests that a history of TBI, even without LOC, is associated with age-related neuropathologic outcomes, both neurodegenerative and vascular. The variation in the neuropathologic outcomes in individuals with and without LOC may provide clues to potential mechanisms, diagnoses, and management in persons with TBI.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Agrawal S, Leurgans SE, James BD, et al. Association of Traumatic Brain Injury With and Without Loss of Consciousness With Neuropathologic Outcomes in Community-Dwelling Older Persons. JAMA Netw Open. 2022. PMID: 35476062. doi:10.1001/jamanetworkopen.2022.9311

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。